National Health Investors, Inc.
NHI
$74.63
-$0.27-0.36%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 275.88M | 271.60M | 267.10M | 268.24M | 263.73M |
| Total Other Revenue | 128.83M | 107.69M | 90.47M | 82.36M | 79.89M |
| Total Revenue | 404.71M | 379.29M | 357.57M | 350.60M | 343.62M |
| Cost of Revenue | 87.70M | 70.50M | 58.11M | 52.77M | 54.55M |
| Gross Profit | 317.01M | 308.79M | 299.47M | 297.82M | 289.07M |
| SG&A Expenses | 29.44M | 29.53M | 27.75M | 26.35M | 24.17M |
| Depreciation & Amortization | 85.48M | 80.94M | 77.97M | 75.52M | 73.10M |
| Other Operating Expenses | 1.03M | 1.08M | 850.00K | 689.00K | 493.00K |
| Total Operating Expenses | 203.64M | 182.06M | 164.68M | 155.34M | 152.31M |
| Operating Income | 201.07M | 197.23M | 192.90M | 195.26M | 191.31M |
| Income Before Tax | 146.72M | 140.79M | 145.77M | 141.54M | 139.80M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 146.72 | 140.79 | 145.77 | 141.54 | 139.80 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.39M | 1.39M | 1.49M | 1.40M | 1.41M |
| Net Income | 148.11M | 142.18M | 147.26M | 142.93M | 141.20M |
| EBIT | 201.07M | 197.23M | 192.90M | 195.26M | 191.31M |
| EBITDA | 286.55M | 278.18M | 270.87M | 270.78M | 264.41M |
| EPS Basic | 3.11 | 3.03 | 3.19 | 3.15 | 3.17 |
| Normalized Basic EPS | 1.89 | 1.87 | 1.83 | 1.88 | 1.88 |
| EPS Diluted | 3.10 | 3.02 | 3.17 | 3.13 | 3.15 |
| Normalized Diluted EPS | 1.89 | 1.87 | 1.82 | 1.87 | 1.87 |
| Average Basic Shares Outstanding | 190.10M | 187.50M | 184.96M | 181.01M | 177.71M |
| Average Diluted Shares Outstanding | 190.88M | 188.21M | 185.76M | 182.12M | 178.86M |
| Dividend Per Share | 3.66 | 3.64 | 3.62 | 3.60 | 3.60 |
| Payout Ratio | 116.81% | 119.36% | 112.14% | 112.99% | 112.29% |